ARTICLE | Company News
Ascentage, Junshi to evaluate APG-1387-toripalimab combo for cancer
April 12, 2019 7:17 PM UTC
Ascentage and Junshi partnered to conduct clinical trials in China evaluating APG-1387 in combination with Tuoyi toripalimab to treat solid tumors and hematological cancers.
Ascentage Pharma Group Corp. Ltd. (Suzhou, China) declined to disclose details, and Shanghai Junshi Biosciences Co. Ltd. (HKSE:1877) did not respond to inquiries...